NeuroOne Medical Tech Analyst Price Targets

Wall Street analyst price targets and consensus rating for NeuroOne Medical Tech (NMTC).

Price Target Range — 5 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$7Upside to Avg. PT+557.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	Maxim Group	Anthony Vendetti	PT Cut	Buy	$13→$5
May 13, 2026	Ladenburg Thalmann	Jeff Cohen	PT Raise	Buy	$2→$8
Mar 2, 2026	Jones Trading	Justin Walsh	Initiate	Buy	$2
Sep 9, 2025	Maxim Group	Anthony Vendetti	Initiate	Buy	$3
May 5, 2025	Ladenburg Thalmann	Jeff Cohen	Initiate	Buy	$1

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5

Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $13 to $5.

Benzinga Newsdesk

PRO
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5

Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $1.5.

Benzinga Newsdesk

PRO
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3

Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $3.

Benzinga Newsdesk

This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

PRO
Ladenburg Thalmann Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.45

Ladenburg Thalmann analyst Jeff Cohen initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $1.45.

Benzinga Newsdesk

Stocks Set To Continue Crashing After Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert

U.S. stock futures continued to decline on Friday after a bloodbath on Thursday following the introduction of Donald Trump's tariffs.

Rishabh Mishra

NeuroOne Medical Technologies Corp

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

NeuroOne Medical Tech Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5

PRO
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5

PRO
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3

This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
Ladenburg Thalmann Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.45

Stocks Set To Continue Crashing After Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert

People Also Watch

People Also Watch

NeuroOne Medical Technologies Corp

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

NeuroOne Medical Tech Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMaxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5

PROJones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5

PROMaxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3

This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROLadenburg Thalmann Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.45

Stocks Set To Continue Crashing After Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert

People Also Watch

People Also Watch

PRO
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5

PRO
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5

PRO
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3

PRO
Ladenburg Thalmann Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.45